1. Home
  2. LAES vs YDES Comparison

LAES vs YDES Comparison

Compare LAES & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.51

Market Cap

675.0M

Sector

Technology

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.30

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
YDES
Founded
2022
2013
Country
Switzerland
Taiwan
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
543.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
LAES
YDES
Price
$2.51
$2.30
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
14.2M
295.3K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$1.70
52 Week High
$8.71
$25.00

Technical Indicators

Market Signals
Indicator
LAES
YDES
Relative Strength Index (RSI) 42.77 47.47
Support Level $2.35 $1.93
Resistance Level $3.40 $2.93
Average True Range (ATR) 0.15 0.33
MACD 0.00 0.05
Stochastic Oscillator 48.28 44.19

Price Performance

Historical Comparison
LAES
YDES

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: